Results 61 to 70 of about 27,014 (195)
Severe fever with thrombocytopenia syndrome virus infection or mixed infection with scrub typhus in South Korea in 2000-2003 [PDF]
Severe fever with thrombocytopenia syndrome is a tick-borne viral disease, with a high mortality rate that was first reported in China in 2009. Scrub typhus is an acute febrile illness caused by Orientia tsutsugamushi, a bacterium transmitted to humans ...
Ro, Hyo-Jin +13 more
core +1 more source
Severe fever with thrombocytopenia syndrome (SFTS) [PDF]
Severe fever with thrombocytopenia syndrome (SFTS), is an emerging infectious zoonotic disease caused by a new phlebovirus, namely Huaiyangshan banyangvirus (family Phenuiviridae, Bunyavirales).
Gliński, Zdzisław, Żmuda, Andrzej
core
ABSTRACT Dengue virus (DENV) poses a serious global health challenge, particularly in cases of dengue hemorrhagic fever (DHF). Patients with preexisting mitochondrial disorders may be at increased risk for complications due to the specific impact of DENV on mitochondrial‐dependent cellular processes and immune function.
Audra N. Iness +11 more
wiley +1 more source
Severe fever with thrombocytopenia syndrome (SFTS) and SFTS virus
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease caused by the SFTS virus (SFTSV), a novel phlebovirus reported to be endemic to China in 2011. In Japan, the first SFTS patient was identified during the autumn of 2012; since then, over 100 SFTS patients have been reported.
openaire +3 more sources
From Interferon Signature to the Clinical Landscape: Type I Interferonopathies
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz +13 more
wiley +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
Dynamics of neutralizing antibodies against severe fever with thrombocytopenia syndrome virus
Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne bunyavirus with a high pathogenicity. Little is known about the longitudinal dynamics of the SFTSV-specific neutralizing antibody (NAb) and the related factors in patients with SFTS.A prospective cohort study of patients with laboratory-confirmed SFTS were ...
Jia-Chen Li +11 more
openaire +3 more sources
Antibodies against Severe Fever with Thrombocytopenia Syndrome Virus in Healthy Persons, China, 2013 [PDF]
In June 2013, a subclinical infection with severe fever with thrombocytopenia syndrome virus (SFTSV) was detected in Zhejiang Province, China, prompting seroprevalence studies in 6 districts within the province.
Huakun Lv +11 more
core +1 more source
Given the central role of protein structures in RNA virus biology, the RNA viral protein structure database (RVPSD, https://virus.9itsg.net) integrates taxonomic classification, viral nucleotide and protein sequences, functional annotations, and predicted three‐dimensional protein structures.
Qiangzhen Yang +8 more
wiley +1 more source
Full-genome sequences of severe fever with thrombocytopenia syndrome virus, isolated from South Korea in 2014 [PDF]
Here, we present the full-length genome sequencing of severe fever with thrombocytopenia syndrome (SFTS) virus, isolated from South Korea in 2014. The five Korean strains were compared by phylogenetic analysis with full SFTS genome sequences of two ...
Lee, Won-Ja +7 more
core +1 more source

